top
Search terms
Results 1 - 10 of 509 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 51
Ehjournal

Nationwide register dataMyocardial infarctionRisk factorsPrognosisMortality See page 1155 for the editorial comment on this article (doi:10.1093/eurheartj/ehv048) Clinical perspective This ...

European Heart Journal, Acute coronary syndrome, Tomas Jernberg, PÃ¥l Hasvold, Martin Henriksson, Hans Hjelm, Marcus Thuresson, Magnus Janzon

Date : 14/05/2015 Item size : 313858 bytes
Ehjournal

Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the ...

European Heart Journal, Fasttrack Clinical, Michael Haude, Hüseyin Ince, Alexandre Abizaid, Ralph Toelg, Pedro Alves Lemos, Clemens von Birgelen, Evald Høj Christiansen, William Wijns, ...

Date : 14/09/2016 Item size : 280276 bytes
Ehjournal

Judy Ozkan speaks with the second ever woman to be Vice President of the European Society of Cardiology Eva Swahn is professor of cardiology and senior consultant in cardiology at the university ...

European Heart Journal, CardioPulse, Judy Ozkan

Date : 21/11/2016 Item size : 121810 bytes
Ehjournal

Questions and answers on diagnosis and risk assessment: a companion document of the 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ...

European Heart Journal, GUIDELINES CLINICAL QUERIES, Authors:, Christian Mueller, Carlo Patrono, Marco Valgimigli, Jean-Philippe Collet, Marco Roffi

Date : 14/01/2016 Item size : 161323 bytes
Ehjournal

In their trial, Cannon et al. report the superiority of the anti-PCSK9 monoclonal antibody (mAb) alirocumab (SAR236553/REGN727; s.c. 75 mg every 2 weeks) over ezetimibe (oral 10 mg once a day) in the ...

European Heart Journal, Editorial, Baris Gencer, François Mach

Date : 14/05/2015 Item size : 244342 bytes
Ehjournal

In the current issue of the journal, Taniwaki et al. propose a significant and biologically relevant association between the presence of in-stent neoatherosclerosis and the progression of native ...

European Heart Journal, Editorial, Kazuyuki Yahagi, Fumiyuki Otsuka, Renu Virmani, Michael Joner

Date : 21/08/2015 Item size : 184588 bytes
Ehjournal

In particular, it appears that inflammatory changes may play an important role as the substrate and trigger of acute coronary events.4,5 Furthermore, novel stents are currently under investigation as ...

European Heart Journal, Issue @ a Glance, Thomas F. Lüscher

Date : 07/02/2015 Item size : 185601 bytes
Ehjournal

Introduction Coronary heart disease (CHD) remains a leading cause of death and disability in Europe and the USA.1,2 Despite major advances in the treatment of atherogenic lipoproteins, substantial ...

European Heart Journal, Lipids, Seth S. Martin, Arif A. Khokhar, Heidi T. May, Krishnaji R. Kulkarni, Michael J. Blaha, Parag H. Joshi, Peter P. Toth, Joseph B. Muhlestein, Jeffrey L. Anderson, ...

Date : 01/01/2015
Ehjournal

Abstract Aims Current statin guidelines in Europe and Canada advocate achieving a fixed LDL target or the attainment of a 50% reduction in low-density lipoprotein cholesterol (LDLC), while current US ...

European Heart Journal, AHA FASTTRACK CLINICAL RESEARCH, Paul M Ridker, Samia Mora, Lynda Rose

Date : 01/05/2016
Ehjournal

[...]cystatin-C levels were higher in patients who did not exhibited fissure or erosion of the culprit plaque, thus suggesting functional mechanisms operating in epicardial coronary arteries or in ...

European Heart Journal, CURRENT OPINION, Frans Van de Werf, Filippo Crea

Date : 07/02/2015